Edition:
United Kingdom

Rhythm Pharmaceuticals Inc (RYTM.OQ)

RYTM.OQ on NASDAQ Stock Exchange Global Market

22.53USD
18 Apr 2018
Change (% chg)

-- (--)
Prev Close
$22.53
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
39,179
52-wk High
$33.80
52-wk Low
$16.89

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.410
Sep '17 0.00 -0.445
Jun '17 0.00 -0.312
Mar '17 0.00 -0.293
FY 2016 Dec '16 0.00 -1.132
Sep '16 0.00 -0.280
Jun '16 0.00 -0.254
Mar '16 0.00 -0.241
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Quarter Ending Sep-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 --
Year Ending Dec-19 3 0.67 2.02 0.00 --
Earnings (per share)
Quarter Ending Jun-18 2 -0.50 -0.48 -0.51 --
Quarter Ending Sep-18 2 -0.54 -0.49 -0.59 --
Year Ending Dec-18 2 -2.18 -1.99 -2.38 --
Year Ending Dec-19 3 -3.04 -2.55 -3.37 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 199.23 33.50
P/E High - Last 5 Yrs. -- 289.53 46.07
P/E Low - Last 5 Yrs. -- 97.02 24.95
Beta -- 0.75 0.80
Price to Sales (TTM) -- 144.40 7.25
Price to Book (MRQ) 4.25 20.58 5.09
Price to Tangible Book (MRQ) 4.25 25.44 6.62
Price to Cash Flow (TTM) -- 129.04 25.50
% Owned Institutions 90.16 11.15 2.24

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.53
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.97 3.92
Payout Ratio(TTM) -- 9.04 20.54

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 80.75 8.68
Sales (TTM) vs TTM 1 Yr. Ago -- 96.50 11.19
Sales - 5 Yr. Growth Rate -- 34.30 8.22
EPS (MRQ) vs Qtr. 1 Yr. Ago -14.84 -65.81 22.73
EPS (TTM) vs TTM 1 Yr. Ago -28.97 -- --
EPS - 5 Yr. Growth Rate -- 48.46 10.28
Capital Spending - 5 Yr. Growth Rate -- 45.85 10.41

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.60 2.53
Current Ratio (MRQ) 22.42 6.05 3.61
LT Debt to Equity (MRQ) 0.00 23.27 11.39
Total Debt to Equity (MRQ) 0.00 25.63 14.02
Interest Coverage (TTM) -- -187.29 39.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 45.96 54.05
Gross Margin - 5 Yr. Avg. -- 55.59 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -148.41 15.90
Operating Margin (TTM) -- -557.58 4.09
Operating Margin - 5 Yr. Avg. -- -160.26 11.23
Pre-Tax Margin (TTM) -- -529.97 4.81
Pre-Tax Margin - 5 Yr. Avg. -- -166.50 11.54
Net Profit Margin (TTM) -- -518.89 1.42
Net Profit Margin - 5 Yr. Avg. -- -166.55 7.87
Effective Tax Rate (TTM) -- -0.18 30.96
Effective Tax Rate - 5 Yr. Avg. -- 18.25 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,228,298 813,295,447
Net Income/Employee (TTM) -1,296,500 1,142,384 95,590,786
Receivable Turnover (TTM) -- 6.52 5.56
Inventory Turnover (TTM) -- 2.30 3.44
Asset Turnover (TTM) -- 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.71 10.51
Return on Assets - 5 Yr. Avg. -- 0.88 11.54
Return on Investment (TTM) -- -0.66 13.17
Return on Investment - 5 Yr. Avg. -- 4.34 14.94
Return on Equity (TTM) -- -2.84 14.98
Return on Equity - 5 Yr. Avg. -- 0.09 16.23
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -150.29 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Rhythm Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 90.16%
# of Holders: 87
Total Shares Held: 24,598,434
3 Mo. Net Change: 28,875
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 5
# Reduced Positions: 2
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.